Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Applied Therapeutics Inc (2UV.BE)

Compare
0.2958
+0.0332
+(12.64%)
At close: April 17 at 9:52:10 PM GMT+2
Loading Chart for 2UV.BE
  • Previous Close 0.2626
  • Open 0.2696
  • Bid 0.2478 x --
  • Ask 0.3352 x --
  • Day's Range 0.2660 - 0.2958
  • 52 Week Range 0.2626 - 9.9400
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 2UV.BE

View More

Performance Overview: 2UV.BE

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

2UV.BE
63.57%
S&P 500 (^GSPC)
10.18%

1-Year Return

2UV.BE
93.70%
S&P 500 (^GSPC)
5.19%

3-Year Return

2UV.BE
84.50%
S&P 500 (^GSPC)
20.26%

5-Year Return

2UV.BE
99.23%
S&P 500 (^GSPC)
83.77%

Compare To: 2UV.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2UV.BE

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    41.37M

  • Enterprise Value

    -25.85M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    103.37

  • Price/Book (mrq)

    0.84

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2UV.BE

View More

Company Insights: 2UV.BE

Research Reports: 2UV.BE

View More